Your Cart Item
Reports Within

Parameters

Reports Within:

Parameter Include:

Requisites
Measures

Number of red blood cells in the blood

Identifies

Red blood cell disorders

Measures: Number of red blood cells in the blood

Identifies: Red blood cell disorders

60
Mins

Homes

1M
Happy

Customers

4.9
Google

Rating

Certified

Labs

What is the maximum days the report can be obtained for the test

The maximum days the report can be obtained for the test MRD For T-ALL Test Flowcytometry is 7 days.

What are the prerequisites for the test MRD For T- ALL Test Flowcytometry

  • Specimen type: Peripheral blood or bone marrow sample
  • Specimen volume: Minimum of 2 mL for peripheral blood and 1 mL for bone marrow
  • Patient preparation: None required
  • Collection container: EDTA tube for peripheral blood and heparin tube for bone marrow
  • Storage conditions: Samples should be kept at room temperature and tested within 24 hours of collection
  • Additional information: Clinical history and relevant laboratory results should be provided along with the sample

What are the measure values for the test MRD For T- ALL Test Flowcytometry

  • MRD Negative: Less than 0.01%
  • MRD Positive: Equal to or greater than 0.01%

What does this test MRD For T- ALL Test Flowcytometry identify?

  • Test: MRD For T-ALL Test Flowcytometry
  • Identifies:
    • Minimal Residual Disease (MRD) in patients with T-cell Acute Lymphoblastic Leukemia (T-ALL)
    • Quantifies the presence of residual leukemic cells in the bone marrow or peripheral blood after treatment
    • Helps in monitoring the response to therapy and predicting the risk of relapse
    • Assists in determining the effectiveness of treatment and making decisions on further management

Why is this test MRD For T- ALL Test Flowcytometry taken?

MRD For T-ALL Test Flowcytometry

Why is this test taken?

The MRD (Minimal Residual Disease) For T- ALL (Acute Lymphoblastic Leukemia) Test Flowcytometry is taken to monitor the effectiveness of treatment in patients with T-ALL. MRD testing is used to detect and quantify small amounts of leukemia cells that may remain in the body after treatment. This test helps to determine if the treatment is working and if any further treatment adjustments are needed to achieve remission.

No FAQs available.

Customer Google Rating